联合扩散张量指标与DSC灌注成像:能否提高鉴别瘤样脱髓鞘病变与高级别胶质瘤的诊断准确性?
本研究纳入14例瘤样脱髓鞘病变和21例高级别胶质瘤患者,评估常规影像、DTI指标(p:q张量分解)及DSC灌注的鉴别价值。常规影像鉴别高级别胶质瘤的敏感度80.9%、特异度57.1%(P=0.049);DTI与DSC参数在强化区ADC、各向同性/各向异性成分、总幅度及rCBV上组间差异有统计学意义(P≤0.02),ADC、各向异性成分及rCBV特异度最高(92.9%);联合DTI与DSC参数AUC=0.901,再加入不均匀强化模式后AUC=0.966,敏感度由71.4%升至85.7%。
要点
- 常规影像鉴别高级别胶质瘤的敏感度80.9%、特异度57.1%。
- 强化区ADC、各向异性成分及rCBV特异度最高,均为92.9%。
- DTI联合DSC参数AUC=0.901,加入不均匀强化模式后AUC=0.966。
核心结论
- DTI与DSC灌注在常规影像基础上显著有助于鉴别瘤样脱髓鞘病变与高级别胶质瘤,两者联合明显提高诊断准确性。
研究设计与样本
- 共纳入14例瘤样脱髓鞘病变和21例高级别胶质瘤患者,行脑MR常规、DTI及DSC灌注成像,通过ROI分析获取强化区及病灶周围高信号区的DTI指标,并计算强化区相对CBV值。
关键影像表现/征象
- 常规影像序列鉴别高级别胶质瘤的敏感度为80.9%、特异度为57.1%(P=0.049)。
- 瘤样脱髓鞘病变与高级别胶质瘤强化区的平均ADC、扩散张量各向同性成分、各向异性成分、总幅度及rCBV差异有统计学意义(P≤0.02)。
- 平均各向异性分数值在瘤样脱髓鞘病变与高级别胶质瘤之间无显著统计学差异。
诊断标准与关键数值
- 常规影像序列鉴别高级别胶质瘤(相对于瘤样脱髓鞘病变)的敏感度80.9%、特异度57.1%(P=0.049)。
- ADC、扩散张量各向异性成分及相对CBV在鉴别中的特异度最高,均为92.9%。
- DTI与DSC参数联合的AUC=0.901;再加入不均匀强化模式后AUC=0.966,敏感度由71.4%升至85.7%。
临床应用与阅片要点
- 阅片时可结合强化区ADC、扩散张量各向异性成分及rCBV辅助鉴别瘤样脱髓鞘病变与高级别胶质瘤。
- 常规影像鉴别困难时,可参考DTI联合DSC参数的AUC=0.901及加入不均匀强化模式后AUC=0.966的结果。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Tumefactive demyelinating lesions with atypical features can mimic high-grade gliomas on conventional imaging sequences. The aim of this study was to assess the role of conventional imaging, DTI metrics (p:q tensor decomposition), and DSC perfusion in differentiating tumefactive demyelinating lesions and high-grade gliomas.
MATERIALS AND METHODS: Fourteen patients with tumefactive demyelinating lesions and 21 patients with high-grade gliomas underwent brain MR imaging with conventional, DTI, and DSC perfusion imaging. Imaging sequences were assessed for differentiation of the lesions. DTI metrics in the enhancing areas and perilesional hyperintensity were obtained by ROI analysis, and the relative CBV values in enhancing areas were calculated on DSC perfusion imaging.
RESULTS: Conventional imaging sequences had a sensitivity of 80.9% and specificity of 57.1% in differentiating high-grade gliomas (P = .049) from tumefactive demyelinating lesions. DTI metrics (p:q tensor decomposition) and DSC perfusion demonstrated a statistically significant difference in the mean values of ADC, the isotropic component of the diffusion tensor, the anisotropic component of the diffusion tensor, the total magnitude of the diffusion tensor, and rCBV among enhancing portions in tumefactive demyelinating lesions and high-grade gliomas (P ≤ .02), with the highest specificity for ADC, the anisotropic component of the diffusion tensor, and relative CBV (92.9%). Mean fractional anisotropy values showed no significant statistical difference between tumefactive demyelinating lesions and high-grade gliomas. The combination of DTI and DSC parameters improved the diagnostic accuracy (area under the curve = 0.901). Addition of a heterogeneous enhancement pattern to DTI and DSC parameters improved it further (area under the curve = 0.966). The sensitivity increased from 71.4% to 85.7% after the addition of the enhancement pattern.
CONCLUSIONS: DTI and DSC perfusion add profoundly to conventional imaging in differentiating tumefactive demyelinating lesions and high-grade gliomas. The combination of DTI metrics and DSC perfusion markedly improved diagnostic accuracy.
引用
- Hiremath SB, Muraleedharan A, Kumar S, et al. Combining Diffusion Tensor Metrics and DSC Perfusion Imaging: Can It Improve the Diagnostic Accuracy in Differentiating Tumefactive Demyelination from High-Grade Glioma? AJNR Am J Neuroradiol. 2017. PMID: 28209583. doi:10.3174/ajnr.A5089
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。